Fintel reports that on January 8, 2025, JMP Securities initiated coverage of Context Therapeutics (NasdaqCM:CNTX) with a ...
You love to see it. With such a gluttony of choice, it became harder than ever for PC hardware and software to impress us. Few products earned our rare Editors’ Choice award. And only the very ...